Supplemental intravenous n-3 fatty acids and n-3 fatty acid status and outcome incritically ill elderly patients in the ICU receiving enteral nutrition

Clinical Nutrition

Volumn 32, Issue 4, 2013, Pages 599-605

  Barros, Karina V ^a,b,c   Cassulino, Ana Paula ^a   Schalch, Lívia ^b   Della Valle Munhoz, Eduardo ^b   Manetta, José Antônio ^b   Noakes, Paul S ^c   Miles, Elizabeth A ^c   Calder, Philip C ^c   Flor Silveira, Vera L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Medical Course   (Brazil)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Critical illness; Fish oil; ICU; Lipid emulsion; Omega 3 fatty acid

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGAVEN; PHOSPHATIDYLCHOLINE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; EMULSION; ENTERIC FEEDING; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GAS EXCHANGE; GERIATRIC PATIENT; HUMAN; INTENSIVE CARE UNIT; LIPID COMPOSITION; MALE; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PROTEIN INTAKE; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; ARACHIDONIC ACID; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EMULSIONS; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; INTENSIVE CARE UNITS; INTERVENTION STUDIES; MALE; NUTRITION ASSESSMENT; PHOSPHATIDYLCHOLINES; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84879464663     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.10.016     Document Type: Article

References (33)

1. Mayer K., Fegbeutel C., Hattar K., Sibelius U.L.F., Kramer H., Heuer K., et al. Omega 3 vs. omega 6 lipid emulsion exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003, 29:1472-1481.
2. Calder P.C. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 2008, 79:101-108.
3. Calder P.C. The 2008 ESPEN Sir David Cuthbertson lecture: fatty acids and inflammation - from the membrane to the nucleus and from the laboratory bench to the clinic. Clin Nutr 2010, 29:5-12.
4. Calder P.C. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011, 668:S50-S58.
5. Calder P.C. Mechanisms of action of (n-3) fatty acids. JNutr 2012, 142:592S-599S.
6. Ott J., Hiesgen C., Mayer K. Lipids in critical care medicine. Prostaglandins Leukot Essent Fatty Acids 2011, 85:267-273.
7. Stapleton R.D., Martin T.R., Weiss N.S., Crowley J.J., Gundel S.J., Nathens A.B., et al. Aphase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 2011, 39:1655-1662.
8. Gadek J.E., DeMichele S.J., Karistad M.D., Pacht E.R., Donahoe M., Albertson T.E., et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral nutrition in ARDS Study Group. Crit Care Med 1999, 27:1409-1420.
9. Pontes-Arruda A., Aragão A.M., Albuquerque J.D. Effects of enteral feeding with eicosapentaenoic acid and gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006, 34:2325-2333.
10. Singer P., Theilla M., Fisher H., Gibstein L., Grozovski E., Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006, 34:1033-1038.
11. Heller A.R., Rossler S., Litz R.J., Stehr S.N., Heller S.C., Koch R., et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979.
12. Barbosa V.M., Miles E.A., Calhau C., Lafuente E., Calder P.C. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acid, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010, 14:R5.
13. Wachtler P., Konig W., Senkal M., Kemen M., Köller M. Influence of a total parenteral nutrition enriched with w-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. JTrauma 1997, 42:191-198.
14. Pittet Y.K., Berger M.M., Pluess T.T., Voirol P., Revelly J.P., Tappy L., et al. Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil. Intensive Care Med 2010, 36:289-295.
15. Versleijen M.W., Roelofs H.M., Rombouts C., Hermans P.W., Noakes P.S., Calder P.C., et al. Short-term infusion of a fish oil-based lipid emulsion modulates fatty acid status, but not immune function or (anti)oxidant balance: a randomized cross-over study. Eur J Clin Invest 2012, 42:290-302.
16. Pluess T.T., Hayoz D., Berger M.M., Tappy L., Revelly J.P., Michaeli B., et al. Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007, 33:789-797.
17. Simoens C.M., Deckelbaum R.J., Massaut J.J., Carpentier Y.A. Inclusion of 10% fish oil in mixed medium-chain triacylglycerol longchain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids. Am J Clin Nutr 2008, 88:282-288.
18. Chumlea W.C., Guo S., Roche A.F., Steinbaugh M.L. Prediction of body weight for the nonambulatory elderly from anthropometry. JAm Diet Assoc 1988, 88:564-568.
19. Burdge G.C., Wright P., Jones A.E., Wootton S.A. Amethod for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 2000, 84:781-787.
20. Calder P.C., Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 2009, 121:148-157.
21. Kew S., Banerjee T., Minihane A.M., Finnegan Y.E., Williams C.M., Calder P.C. Relation between the fatty acid composition of peripheral blood mononuclear cells and measures of immune cell function in healthy, free-living subjects aged 25-72y. Am J Clin Nutr 2003, 77:1278-1286.
22. Browning L.M., Walker C.G., Mander A.P., West A.L., Madden J., Gambell J.M., et al. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr 2012, 96:748-758.
23. Rice T.W., Wheeler A.P., Thompson B.T., deBoisblanc B.P., Steingrub J., Rock P. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAm Med Assoc 2011, 12:1574-1581. NIHNHLBI Acute Respiratory Distress Syndrome Network of Investigators.
24. Gupta A., Govil D., Bhatnagar S., Gupta S., Goyal J., Patel S., et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian J Crit Care Med 2011, 15:108-113.
25. Rioux V., Pédrono F., Legrand P. Regulation of mammalian desaturases bymyristic acid: N-terminal myristoylation and other modulations. Biochim Biophys Acta 2011, 1811:1-8.
26. Rioux V., Catheline D., Bouriel M., Legrand P. Dietary myristic acid at physiologically relevant levels increases the tissue content of C20:5 n-3 and C20:3 n-6 in the rat. Reprod Nutr Dev 2005, 45:599-612.
27. Smith D.L., Willis A.L., Nguyen N., Conner D., Zahedi S., Fulks J. Eskimo plasmaconstituents, dihomo-gamma-linolenic acid, eicopentanoic acid and docosahexaenoic acid, inhibit the release of atherogenic mitogens. Lipids 1989, 24:70-75.
28. Nakamura N., Hamazaki T., Taki H., Yamazaki K., Kobayashi M. Intravenous infusion of tridihomo-gamma-linolenoyl-glycerol reduces leukotriene B4 production in the rat and rabbit. Clin Sci (Lond) 1993, 84:511-516.
29. Umeda-Sawada R., Fujiwara Y., Ushiyama I., Sagawa S., Morimitsu Y., Kawashima H., et al. Distribution and metabolism of dihomo-g-linolenic acid (DGLA, 20:3n-3) by oral supplementation in rats. Biosci Biotechnol 2006, 70:2121-2130.
30. Serhan C.N., Chiang N., van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
31. Wang X., Li W., Li N., Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JParenter Enteral Nutr 2008, 32:236-241.
32. Nierman D.M., Schechter C.B., Cannon L.M., Meier D.E. Outcome prediction model for very elderly critically ill patients. Crit Care Med 2001, 29:1853-1859.
33. Anon JM, Gomez-Tello V, Gonzales-Higueras E, Cordoles V, Quintana M, Lorenzo AG, etal. Prognosis of elderly patients subjected to mechanical ventilation in the ICU. Med Intensiva, in press.